Antonio José Leal Costa

Dr. Antonio José Leal Costa

Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2009 in Thyroid®
Verified
Journal Article
Closed access
PTPatrícia De Fátima Dos Santos Teixeira
Patrícia De Fátima Dos Santos Teixeira
MCMônica D. Cabral
Mônica D. Cabral
NSNathalie A. Silva
Nathalie A. Silva
DSDébora V. Soares
Débora V. Soares
VBValéria B. Braulio
Valéria B. Braulio
MVMário Vaisman
Mário Vaisman
Background: The relationship between thyroid status, including subclinical hypothyroidism (SH) and serum leptin is controversial or uncertain. Therefore we evaluated serum leptin in SH and overt hypothyroidism (OH) and determined the effects of levothyroxine (LT 4 ) replacement on serum leptin in these disorders. Methods: Serum leptin, thyrotropin (TSH), free thyroxine, insulin, glucose, and body composition parameters were compared in 55 SH, 20 OH, and 28 euthyroid (EU) pre- and postmenopausal women. In addition, the effect of LT 4 treatment on serum leptin in SH and OH was assessed. Results: The mean ± SD (median) serum leptin concentrations in the OH and SH groups were higher than in the EU group (35.1 ± 27.2 [33.0] and 36.6 ± 21.9 [30.6] ng/mL, respectively, vs. 23.2 ± 19.3 [17.9] ng/mL, p = 0.011), but the difference was only significant in postmenopausal women. The body mass index (BMI), fat mass index (FMI), and the homeostasis model assessment–insulin resistance (HOMA-IR) index values were not different among these groups. In premenopausal women there was no correlation between leptin, BMI, or FMI and serum TSH levels ( r s = 0.009, p = 0.474; r s = 0.043, p = 0.367; r s = 0.092, p = 0.232). In the postmenopausal women, the partial correlation coefficient between TSH and leptin was present, even when controlling for BMI ( r s = 0.297, p = 0.042) and FMI ( r s = 0.275, p = 0.050). LT 4 treatment was associated with a reduction of serum leptin concentrations in the OH group ( p = 0.008). In SH group there were no differences between LT 4 replacement or no treatment, since a fall in serum leptin levels was detected in both SH subgroups, despite a more pronounced fall with LT 4 use. Treatment of the SH and OH groups with LT 4 did not influence HOMA-IR index or body composition. Conclusions: Serum leptin concentrations are elevated in postmenopausal women with SH or OH. A relationship between thyroid status and serum leptin is further supported by the fact that LT 4 treatment, to restore the EU status, reduced serum leptin levels in OH in the absence of significant effects on BMI. In women, hypothyroidism influences either leptin secretion or degradation and this effect is more pronounced in postmenopausal than in premenopausal women.

1 December 2006 in Ciencia & Saude Coletiva
Verified
Journal Article
Closed access
PDF file
LBLigia Bahia
Ligia Bahia
RLRonir Raggio Luiz
Ronir Raggio Luiz
CSCláudio Salm
Cláudio Salm
ACAntonio José Leal Costa
Antonio José Leal Costa
PKPauline Lorena Kale
Pauline Lorena Kale
MCMaria de Lourdes T. Cavalcanti
Maria de Lourdes T. Cavalcanti
A partir dos dados do Suplemento Saúde da PNAD 1998, diversos estudos evidenciaram a presença de diferenças significativas nos padrões socioeconômicos, acesso, utilização de serviços de saúde e condições de saúde entre os segmentos populacionais cobertos e não cobertos por planos de saúde. Buscando contribuir para aprimorar o acervo dos conhecimentos sobre a estrutura e a dinâmica do mercado de planos e seguros de saúde no Brasil, admite-se e procura-se evidenciar a heterogeneidade dessas demandas. Para tanto, foi definida uma tipologia de planos de saúde, fundamentada nas origens institucionais das demandas e, subseqüentemente, pelas relações de dependência com titulares de planos e seguros de saúde, integrada por três categorias principais: os planos empresariais privados, os planos empresariais públicos e os planos individuais. As características etárias, socioeconômicas e de condições de saúde variam segundo os diferentes tipos de plano, sugerindo a presença de padrões distintos de demandas, especialmente entre os planos empresariais privados e os planos individuais.

1 January 2020 in Ciencia & Saude Coletiva
Verified
Journal Article
Open access
PDF file
PBPatrícia Carvalho da Silva Balieiro
Patrícia Carvalho da Silva Balieiro
LSLeila Cristina Ferreira da Silva
Leila Cristina Ferreira da Silva
VSVANDERSON SOUZA SAMPAIO
VANDERSON SOUZA SAMPAIO
EMEyrivania Xavier Do Monte
Eyrivania Xavier Do Monte
EPEdylene Maria dos Santos Pereira
Edylene Maria dos Santos Pereira
ACAntonio José Leal Costa
Antonio José Leal Costa
Resumo Objetivou-se investigar fatores associados à mortalidade por causas inespecíficas e mal definidas no estado do Amazonas (AM). Desenvolveu-se um estudo seccional incluindo 90.439 registros de óbitos não fetais, com residência e ocorrência no AM entre 2006 e 2012. Foram estimadas razões de chances de causas inespecíficas e mal definidas por meio de regressão logística multinomial hierárquica. A proporção de causas mal definidas e inespecíficas foi, respectivamente, 16,6% e 9,1%. A ocorrência de causas mal definidas diminuiu ao longo dos anos e a de causas inespecíficas somente no último biênio. As causas inespecíficas associaram-se com residência e ocorrência do óbito fora da capital, via pública, sexo feminino, dos 10 aos 49 anos, cor parda e quando atestadas por legistas. As causas mal definidas associaram-se com residência e ocorrência fora da capital, em domicílios, a partir de 40 anos, cor não branca, não ser solteiro, baixa escolaridade, assistência médica e falta de informação sobre o atestante. A mortalidade por causas mal definidas e inespecíficas no AM declinou entre 2006 e 2012, associando-se às dimensões espacial e temporal, fatores demográficos, socioeconômicos e à assistência médica na ocasião do óbito.

19 April 2015 in BMC Public Health
Verified
Journal Article
Open access
PDF file
PKPauline Lorena Kale
Pauline Lorena Kale
SFSandra Costa Fonseca
Sandra Costa Fonseca
KSKátia Silveira da Silva
Kátia Silveira da Silva
PRPenha Maria Mendes da Rocha
Penha Maria Mendes da Rocha
RSRosana Garcia Silva
Rosana Garcia Silva
TTTania Zdenka Guillén de Torres
Tania Zdenka Guillén de Torres
Smoking epidemic in Brazilian women has later onset, smaller magnitude, and slower decreasing trend, compared to men. Among pregnant women, smoking has an additional deleterious effect. The purpose of this study was to analyze smoking prevalence during pregnancy and associated factors, and to describe the frequency of smoking reduction and cessation in public maternities of Rio de Janeiro State, southeastern Brazil, in 2011. A cross-sectional study was conducted in two maternities located at public hospitals in two cities of the Rio de Janeiro state, Niterói (maternity A) and of Rio de Janeiro (maternity B). Data were gathered by interviews 12 hours after the delivery, and analyses of prenatal cards and medical records. Smoking prevalence according to maternal characteristics, adequacy of prenatal care, and proportions of smoking reduction and cessation during pregnancy were calculated. Factors associated to smoking during pregnancy were estimated by logistic regression analysis. Smoking prevalence at maternity A (24.8%, 95% CI: 21.1-29.0) and maternity B (17.9%, 95% CI: 15.8-20.1) were high. Prevalence rates were greater in women aged 20-34 years, mainly without partner, multiparous and brown or black skin color. Low education (OR = 2.14, 95% CI 1.21, 3.79) and multiparity (OR = 3.48, 95% CI 1.78, 6.81), at maternity A; adolescence (OR = 0.44, 95% CI 0.26, 0.75), black skin color (OR = 1.71, 95% CI 1.06, 2.74), low education (OR = 1.61, 95% CI 1.08, 2.40), and multiparity (OR = 1.58, 95% CI 1.03, 2.44), at maternity B, were associated with smoking in multivariable analysis. Adequacy of prenatal care and smoking prevalence showed an inverse association. More than half of the smokers kept the smoking habits during pregnancy. Reduction occurred mainly between the 1st and 2nd trimesters of pregnancy. Smoking prevalence during pregnancy was higher for multiparous and less educated women. Population and individual strategies for smoking prevention and control must include actions specific for women, especially during the reproductive period.

22 May 2024 in Journal of Epidemiology and Global Health
Verified
Journal Article
Open access
PDF file
VBVictoria Virginia Beeks
Victoria Virginia Beeks
Souzana AchilleosSouzana Achilleos
Souzana Achilleos
AQAnnalisa Quattrocchi
Annalisa Quattrocchi
CPChryso Th. Pallari
Chryso Th. Pallari
ECElena Critselis
Elena Critselis
TCThe C-MOR Consortium
The C-MOR Consortium
Background: This study investigated cause-specific mortality rates in 12 countries during the COVID-19 pandemic in 2020 and 2021. Methods: We collected weekly cause-specific mortality data from respiratory disease, pneumonia, cardiovascular disease (CVD) and cancer from national vital statistic databases. We calculated excess mortality for respiratory disease (excluding COVID-19 codes), pneumonia, and CVD in 2020 and 2021 by comparing observed weekly against expected mortality based on historical data (2015–2019), accounting for seasonal trends. We used multilevel regression models to investigate the association between country-level pandemic-related variables and cause-specific mortality. Results: Significant reductions in cumulative mortality from respiratory disease and pneumonia were observed in 2020 and/or 2021, except for Georgia, Northern Ireland, Kazakhstan, and Ukraine, which exhibited excess mortality for one or both causes. Australia, Austria, Cyprus, Georgia, and Northern Ireland experienced excess cumulative CVD mortality in 2020 and/or 2021. Australia, Austria, Brazil, Cyprus, Georgia, Northern Ireland, Scotland and Slovenia, experienced increased crude cumulative cancer mortality during 2020 and/or 2021 compared to previous years. Among pandemic-related variables, reported COVID-19 incidence was negatively associated with increased cancer mortality, excess respiratory, (2020) and pneumonia (2021) mortality, and positively associated with respiratory and CVD mortality (2021). Stringency of control measures were negatively associated with excess respiratory disease, CVD, and increased cancer mortality (2021). Conclusions: This study provides evidence of substantial excess mortality from CVD, and notable reductions in respiratory disease and pneumonia in both years across most countries investigated. Our study also highlights the beneficial impact of stringent control measures in mitigating excess mortality from most causes in 2021.

1 November 2011 in Annals of Epidemiology
Verified
Journal Article
Closed access
ACAntonio José Leal Costa
Antonio José Leal Costa
PKPauline Lorena Kale
Pauline Lorena Kale
RLRonir Luiz
Ronir Luiz
SMSuzana Alves De Moraes
Suzana Alves De Moraes
TMThomas H. Mosley
Thomas H. Mosley
MSMoyses Szklo
Moyses Szklo